Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Milpharm Limited, Ares, Odyssey Business Park, West End Road, South Ruislip HA4 6QD, United Kingdom
Sotalol 40mg Tablets.
| Pharmaceutical Form |
|---|
|
Tablet. Round, white to off-white, flat bevelled edged tablets. |
Each tablet contains 40mg Sotalol hydrochloride.
For excipients: see 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Sotalol |
D,l-sotalol is a non-selective hydrophilic β-adrenergic receptor blocking agent, devoid of intrinsic sympathomimetic activity or membrane stabilizing activity. Sotalol has both beta-adrenoreceptor blocking (Vaughan Williams Class II) and cardiac action potential duration prolongation (Vaughan Williams Class III) antiarrhythmic properties. |
| List of Excipients |
|---|
|
Calcium hydrogen phosphate dihydrate |
The tablets are packed in 14-tablets blisters constituted from PVC/PVdC and aluminium foil.
Pack sizes: 28 and 56 tablets.
Milpharm Limited, Ares, Odyssey Business Park, West End Road, South Ruislip HA4 6QD, United Kingdom
PL16363/0175
18th July 2005
| Drug | Countries | |
|---|---|---|
| SOTALOL | Netherlands |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
